Netarsudil 0.02%/latanoprost 0.005% ophthalmic solution

DRUG2 trials

Sponsors

Alcon Research

Conditions

Ocular HypertensionOpen Angle Glaucoma

Phase 2

Next Generation Rocklatan

CompletedNCT06441643

Alcon ResearchOcular Hypertension, Open Angle Glaucoma

Start: 2024-09-04End: 2025-11-14Updated: 2025-11-18

Phase 3

Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction

Active, not recruitingNCT07082816

Alcon ResearchOcular Hypertension, Open Angle Glaucoma

Start: 2025-09-02End: 2026-05-31Updated: 2026-01-13